These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 169212

  • 1. Nonsuppressible insulin-like activity: biological activity and receptor binding.
    Zapf J, Mäder M, Waldvogel M, Froesch ER.
    Isr J Med Sci; 1975 Jul; 11(7):664-78. PubMed ID: 169212
    [No Abstract] [Full Text] [Related]

  • 2. Insulin receptors in fat cells: relationship between binding and activation.
    Gliemann J, Gammeltoft S, Vinten J.
    Isr J Med Sci; 1975 Jul; 11(7):656-63. PubMed ID: 169211
    [No Abstract] [Full Text] [Related]

  • 3. Structure and activity of the B-chain of insulin.
    Ng FM, Zhu SQ, Cui DF, Fan L, Huang YD, Zhang YS.
    Biochem Int; 1989 Feb; 18(2):373-81. PubMed ID: 2669756
    [Abstract] [Full Text] [Related]

  • 4. Oxytocin action. Mechanisms for insulin-like activity in isolated rat adipocytes.
    Hanif K, Goren HJ, Hollenberg MD, Lederis K.
    Mol Pharmacol; 1982 Sep; 22(2):381-8. PubMed ID: 6292696
    [No Abstract] [Full Text] [Related]

  • 5. Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulinlike growth factor) using antibodies to the insulin receptor.
    King GL, Kahn CR, Rechler MM, Nissley SP.
    J Clin Invest; 1980 Jul; 66(1):130-40. PubMed ID: 6995478
    [Abstract] [Full Text] [Related]

  • 6. Common mechanism of action of somatomedin and insulin on fat cells. Further evidence.
    Clemmons DR, Hintz RL, Underwood LE, Van Wyk JJ.
    Isr J Med Sci; 1974 Oct; 10(10):1254-62. PubMed ID: 4373414
    [No Abstract] [Full Text] [Related]

  • 7. Recent studies on insulin-receptor interactions.
    Freychet P.
    Isr J Med Sci; 1975 Jul; 11(7):679-86. PubMed ID: 169213
    [No Abstract] [Full Text] [Related]

  • 8. [Metabolic effects of arginine derivatives. 3. Insulin-like activity of L-arginine-N,N-dialkylamides in vitro].
    Weitzel G, Stock W, Guglielmi H.
    Hoppe Seylers Z Physiol Chem; 1972 Nov; 353(11):1661-70. PubMed ID: 4346147
    [No Abstract] [Full Text] [Related]

  • 9. Biological properties of NSILA-S.
    Froesch ER, Zapf J, Meuli C, Mäder M, Waldvogel M, Kaufmann U, Morell B.
    Adv Metab Disord; 1975 Nov; 8():211-35. PubMed ID: 1106155
    [No Abstract] [Full Text] [Related]

  • 10. [Insulin binding to isolated cells].
    Keilacker H, Ziegler M, Knospe S, Ziegler B, Besch W.
    Acta Biol Med Ger; 1978 Nov; 37(4):601-11. PubMed ID: 735628
    [Abstract] [Full Text] [Related]

  • 11. Isolation and characterization of hormone receptors.
    Cuatrecasas P.
    Neurosci Res Program Bull; 1973 Jun; 11(3):215-9. PubMed ID: 4351990
    [No Abstract] [Full Text] [Related]

  • 12. [Insulin receptors-a review (author's transl)].
    Freychet P.
    Diabete Metab; 1975 Mar; 1():57-68. PubMed ID: 791721
    [Abstract] [Full Text] [Related]

  • 13. The signaling potential of the receptors for insulin and insulin-like growth factor I (IGF-I) in 3T3-L1 adipocytes: comparison of glucose transport activity, induction of oncogene c-fos, glucose transporter mRNA, and DNA-synthesis.
    Weiland M, Bahr F, Höhne M, Schürmann A, Ziehm D, Joost HG.
    J Cell Physiol; 1991 Dec; 149(3):428-35. PubMed ID: 1660482
    [Abstract] [Full Text] [Related]

  • 14. Multiplication stimulating activity (MSA) from the BRL 3A rat liver cell line: relation to human somatomedins and insulin.
    Rechler MM, Nissley SP, King GL, Moses AC, Van Obberghen-Schilling EE, Romanus JA, Knight AB, Short PA, White RM.
    J Supramol Struct Cell Biochem; 1981 Dec; 15(3):253-86. PubMed ID: 6267316
    [Abstract] [Full Text] [Related]

  • 15. Biological effects of the insulin-like growth factors in vitro: relevance to their actions in vivo.
    Zapf J, Schoenle E, Widmer U, Froesch ER.
    Bull Schweiz Akad Med Wiss; 1981 Dec; ():171-82. PubMed ID: 6764149
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of pancreatic human and biosynthetic human insulin with respect to their action on adipocytes and chick embryo fibroblasts.
    Zapf J, Froesch ER.
    Diabetes Care; 1981 Dec; 4(2):257-9. PubMed ID: 7011741
    [Abstract] [Full Text] [Related]

  • 17. Binding of nonsuppressible insulin-like activity (NSILA) to isolated fat cells: evidence for two separate membrane acceptor sites.
    Schoenle E, Zapf J, Froesch ER.
    FEBS Lett; 1976 Aug 15; 67(2):175-9. PubMed ID: 182551
    [No Abstract] [Full Text] [Related]

  • 18. The biological activity and the binding affinity of modified insulins determined on isolated rat fat cells.
    Gliemann J, Gammeltoft S.
    Diabetologia; 1974 Apr 15; 10(2):105-13. PubMed ID: 4367434
    [No Abstract] [Full Text] [Related]

  • 19. Nonsuppressible insulin-like activity of human serum. A potent inhibitor of insulin degradation.
    Kahn CR, Megyesi K, Roth J.
    J Clin Invest; 1976 Feb 15; 57(2):526-9. PubMed ID: 1254732
    [Abstract] [Full Text] [Related]

  • 20. Somatomedins (first of two parts).
    Phillips LS, Vassilopoulou-Sellin R.
    N Engl J Med; 1980 Feb 14; 302(7):371-80. PubMed ID: 6243390
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.